Defence Therapeutics Inc (DTC.CX)
0.51
+0.01
(+2.00%)
CAD |
CNSX |
Aug 25, 16:00
Defence Therapeutics Total Liabilities (Quarterly) : 4.031M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.031M |
| December 31, 2025 | 2.593M |
| September 30, 2025 | 4.176M |
| June 30, 2025 | 2.907M |
| March 31, 2025 | 2.583M |
| December 31, 2024 | 3.857M |
| September 30, 2024 | 4.546M |
| June 30, 2024 | 4.062M |
| March 31, 2024 | 3.266M |
| December 31, 2023 | 2.964M |
| September 30, 2023 | 2.029M |
| June 30, 2023 | 1.966M |
| Date | Value |
|---|---|
| March 31, 2023 | 1.818M |
| December 31, 2022 | 2.548M |
| September 30, 2022 | 1.233M |
| June 30, 2022 | 1.107M |
| March 31, 2022 | 0.3121M |
| December 31, 2021 | 0.2841M |
| September 30, 2021 | 0.3171M |
| June 30, 2021 | 0.1223M |
| March 31, 2021 | 0.1569M |
| December 31, 2020 | 0.0756M |
| September 30, 2020 | |
| June 30, 2020 | 0.0484M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spectral Medical, Inc. | 73.26M |
| Resverlogix Corp. | 145.46M |
| Theratechnologies, Inc. | 108.88M |
| COSCIENS Biopharma, Inc. | 5.688M |
| Restart Life Sciences Corp. | 0.7405M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.446M |
| Shareholders Equity (Quarterly) | 5.415M |
| Debt to Equity Ratio | 0.2889 |
| Current Ratio | 3.367 |
| Net Debt Paydown Yield | -0.13% |